237
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation

ORCID Icon, ORCID Icon & ORCID Icon
Pages 62-77 | Received 28 Jul 2017, Accepted 04 Jan 2018, Published online: 22 Jan 2018

References

  • Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J Control Release, 2006;111:145–52.
  • Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol, 2003;55:1451–63.
  • Araújo J, Nikolic S, Egea MA, Souto EB, Garcia ML. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf B Biointerfaces, 2011;88:150–7.
  • Baig MS, Ahad A, Aslam M, Imam SS, Aqil M, Ali A. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Int J Biol Macromol, 2016;85:258–70.
  • Boddu SH, Gupta H, Patel S. Drug delivery to the back of the eye following topical administration: An update on research and patenting activity. Recent Pat Drug Deliv Formul, 2014;8:27–36.
  • Chien D-S, Homsy JJ, Gluchowski C, Tang-Liu DD. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr Eye Res, 1990;9:1051–9.
  • Chong EWT, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. A systematic review and meta-analysis. Arch Ophthalmol, 2008;126:826–33.
  • De Salamanca AE, Diebold Y, Calonge M, Garci´a-Vazquez C, Callejo S, Vila A, Alonso MJ. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci, 2006;47:1416–25.
  • Derendorf H, Hochhaus G, Rohatagi S, Möllmann H, Barth J, Sourgens H, Erdmann M. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol, 1995;35:302–5.
  • Epand RM, Epand RF, Ahmed N, Chen R. Promotion of hexagonal phase formation and lipid mixing by fatty acids with varying degrees of unsaturation. Chem Phys Lipids, 1991;57:75–80.
  • Gao XC, Qi HP, Bai JH, Huang L, Cui H. Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes. Curr Eye Res, 2014;39:1161–8.
  • Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J, 2010;12:348–60.
  • Goskonda VR, Khan MA, Hutak CM, Reddy IK. Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells. J Pharm Sci, 1999;88:180–4.
  • Hironaka K, Inokuchi Y, Tozuka Y, Shimazawa M, Hara H, Takeuchi H. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release, 2009;136:247–53.
  • Hodge WG, Schachter HM, Barnes D, Pan Y, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: A systematic review. Ophthalmology, 2006;113:1165–72.
  • Hong JY, Kim JK, Song YK, Park JS, Kim CK. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release, 2006;110:332–8.
  • Hossain Z, Kurihara H, Hosokawa M, Takahashi K. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells. Mol Cell Biochem, 2006;285:155–63.
  • Ibarguren M, Lopez DJ, Escriba PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta, 2014;1838:1518–28.
  • Ibrahim SS, Awad GA, Geneidi A, Mortada ND. Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. Colloids Surf B Biointerfaces, 2009;69:225–31.
  • Inokuchi Y, Hironaka K, Fujisawa T, Tozuka Y, Tsuruma K, Shimazawa M, Takeuchi H, Hara H. Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration. Invest Ophthalmol Vis Sci, 2010;51:3162–70.
  • Jager RD, AIELLO LP, Patel SC, Cunningham Jr ET. Risks of intravitreous injection: A comprehensive review. Retina (Philadelphia, Pa.), 2004;24:676–98.
  • Janoria KG, Gunda S, Boddu SH, Mitra AK. Novel approaches to retinal drug delivery. Expert Opin Drug Deliv, 2007;4:371–88.
  • Jonas JB. Intravitreal triamcinolone acetonide: A change in a paradigm. Ophthalmic Res, 2006;38:218–45.
  • Joshi K. Docosahexaenoic acid content is significantly higher in ghrita prepared by traditional Ayurvedic method. J Ayurveda Integr Med, 2014;5:85.
  • Kamboj S, Rana V. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. Int J Pharm, 2016;501:311–25.
  • Kaur IP, Kakkar S. Nanotherapy for posterior eye diseases. J Control Release, 2014;193:100–12.
  • Kaur IP, Kapil M, Smitha R, Aggarwal D. Development of topically effective formulations of acetazolamide using HP-β-CD-polymer co-complexes. Curr Drug Deliv, 2004;1:65–72.
  • Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm, 2002;28:353–69.
  • Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J Control Release, 2002;81:65–74.
  • Khunt D, Shah B, Misra M. Role of butter oil in brain targeted delivery of Quetiapine fumarate microemulsion via intranasal route. J Drug Deliv Sci Technol, 2017;40:11–20.
  • Kitessa SM, Gulati SK, Simos GC, Ashes JR, Scott TW, Fleck E, Wynn PC. Supplementation of grazing dairy cows with rumen-protected tuna oil enriches milk fat with n-3 fatty acids without affecting milk production or sensory characteristics. Br J Nutr, 2004;91:271–7.
  • Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces, 2014;117:82–8.
  • Lapshina EA, Zavodnik IB, Bryszewska M. Effect of free fatty acids on the structure and properties of erythrocyte membrane. Scand J Clin Lab Invest, 1995;55:391–7.
  • Li X, Pan W, Ju C, Liu Z, Pan H, Zhang H, Nie S. Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes. Drug Deliv, 2009;16:224–9.
  • Liu Z, Li J, Nie S, Guo H, Pan W. Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol, 2006;58:45–50.
  • Liu Z, Zhang X, Li J, Liu R, Shu L, Jin J. Effects of Labrasol on the corneal drug delivery of baicalin. Drug Deliv, 2009;16:399–404.
  • Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res, 1977; 25:577–82.
  • Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol, 2005;40:63–8.
  • Piao HM, Balakrishnan P, Cho HJ, Kim H, Kim YS, Chung SJ, Shim CK, Kim DD. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm, 2010;395:309–16.
  • Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev, 1997;25:47–58.
  • Reichl S. Cell culture models of the human cornea – A comparative evaluation of their usefulness to determine ocular drug absorption in-vitro. J Pharm Pharmacol, 2008;60:299–307.
  • Rodrigues LB, Leite HF, Yoshida MI, Saliba JB, Junior AS, Faraco AA. In vitro release and characterization of chitosan films as dexamethasone carrier. Int J Pharm, 2009;368:1–6.
  • Schoenwald RD, Huang HS. Corneal penetration behavior of β‐blocking agents I: Physicochemical factors. J Pharm Sci, 1983;72:1266–72.
  • Schoenwald RD, Deshpande GS, Rethwisch DG, Barfknecht CF. Penetration into the anterior chamber via the conjunctival/sclera pathway. J Ocul Pharmacol Ther, 1997;13:41–59.
  • Shah B, Khunt D, Misra M, Padh H. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. Eur J Pharm Sci, 2016;91:196–207.
  • Shah B, Misra M, Shishoo CJ, Padh H. Nose to brain microemulsion-based. Drug delivery system of rivastigmine: Formulation and ex-vivo characterization. Drug Deliv, 2015;22:918–30.
  • Sood S, Jain K, Gowthamarajan K. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces, 2014;113:330–7.
  • Sserunjogi ML, Abrahamsen RK, Narvhus J. A review paper: Current knowledge of ghee and related products. Int Dairy J, 1998;8:677–88.
  • Tak RV, Pal D, Gao H, Dey S, Mitra AK. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC‐rabbit corneal epithelial cell line. J Pharm Sci, 2001;90:1505–15.
  • Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol, 2006;141:629.
  • Ulatowski F, Dabrowa K, Bałakier T, Jurczak J. Recognizing the limited applicability of job plots in studying host–guest interactions in supramolecular chemistry. J Org Chem, 2016;81:1746–56.
  • Ustundag-Okur N, Gokçe EH, Egrilmez S, Ozer O, Ertan G. Novel ofloxacin-loaded microemulsion formulations for ocular delivery. J Ocul Pharmacol Ther, 2014;30:319–32.
  • Varshochian R, Riazi‐Esfahani M, Jeddi‐Tehrani M, Mahmoudi AR, Aghazadeh S, Mahbod M, Movassat M, Atyabi F, Sabzevari A, Dinarvand R. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A, 2015;103:3148–56.
  • Ying L, Tahara K, Takeuchi H. Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: Effect of emulsion formulations and surface modification. Int J Pharm, 2013;453:329–35.
  • Zambito Y, Di Colo G. Chitosan and its derivatives as intraocular penetration enhancers. J Drug Deliv Sci Technol, 2010;20:45–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.